rna
interfer
rnai
evolutionarili
conserv
mechan
sequencespecif
target
rna
degrad
anim
plant
play
essenti
role
gene
regul
addit
believ
function
defens
virus
transposon
recent
year
rnai
becom
wide
use
approach
studi
gene
function
target
cleavag
specif
rna
moreov
technolog
develop
new
therapeut
option
alreadi
made
way
clinic
test
treatment
viral
infect
remain
seriou
challeng
due
emerg
new
virus
strain
variat
among
known
viru
speci
rnai
hold
great
promis
provid
flexibl
approach
rapidli
adapt
new
viral
target
sequenc
major
challeng
develop
effici
rnai
approach
still
remain
design
small
interf
rna
sirna
high
silenc
potenc
larg
librari
valid
sirna
exist
silenc
endogen
express
gene
human
murin
cell
sirna
still
design
individu
new
antivir
approach
present
chapter
describ
strategi
design
highli
potent
sirna
take
consider
thermodynam
featur
sirna
well
structur
restrict
target
rna
furthermor
assay
test
sirna
report
assay
well
option
improv
properti
sirna
introduct
modifi
nucleotid
describ
final
experiment
setup
outlin
test
sirna
assay
infecti
virus
wellknown
virus
like
influenza
viru
caus
pandem
global
dimens
thu
press
unmet
medic
need
develop
new
antivir
drug
small
molecul
domin
antivir
decad
biolog
like
monoclon
antibodi
nucleic
acid
therapi
recent
consid
promis
altern
among
variou
oligonucleotidebas
strategi
rna
interfer
rnai
wide
regard
particularli
power
technolog
rnai
posttranscript
gene
silenc
mechan
trigger
doublestrand
rna
applic
mammalian
cell
small
interf
rna
sirna
approxim
base
pair
two
nucleotid
overhang
end
strand
becom
incorpor
rnainduc
silenc
complex
risc
induc
cleavag
complementari
target
rna
within
year
rnai
becom
standard
molecular
biolog
method
studi
gene
function
moreov
technolog
develop
new
therapeut
approach
approxim
dozen
clinic
trial
base
rnai
current
underway
among
trial
variou
applic
rnai
treat
infect
respiratori
syncyti
viru
hbv
hiv
silenc
endogen
express
gene
becom
routin
procedur
predesign
valid
sirna
silenc
guarante
virtual
human
murin
gene
commerci
avail
contrast
design
sirna
high
antivir
activ
still
remain
challeng
task
sever
featur
describ
influenc
success
rnai
approach
thermodynam
design
sirna
structur
sirna
antisens
strand
structur
target
rna
public
avail
tool
design
sirna
exclus
optim
base
composit
sirna
recent
howev
design
algorithm
develop
select
sirna
particularli
high
potenc
specif
focus
design
sirna
also
take
consider
secondari
structur
sirna
target
site
major
challeng
longterm
inhibit
virus
rnai
prevent
viral
escap
thu
sirna
need
direct
wellconserv
target
site
unfortun
simpli
direct
sirna
protein
code
region
insuffici
sinc
silent
mutat
caus
sirna
lose
inhibitori
potenti
target
region
import
function
structur
rna
may
prove
better
choic
avoid
viral
escap
exampl
shown
sirna
highli
conserv
cisact
replic
element
cre
capabl
inhibit
variou
enterovirus
long
period
sirna
target
proteinencod
region
rna
organ
function
three
dimension
structur
led
rapid
viral
escap
sinc
even
care
select
singl
target
site
might
insuffici
sustain
viral
silenc
use
multipl
sirna
multipl
target
site
may
necessari
prevent
viral
escap
case
coxsackieviru
resist
rapidli
emerg
singl
molecul
use
combin
three
four
sirna
respect
target
distinct
region
genom
abl
prevent
emerg
resist
gener
requir
applic
rnai
vivo
stabil
sirna
introduct
modifi
nucleotid
base
experi
antisens
field
numer
modifi
nucleotid
assess
applic
enhanc
stabil
sirna
nucleas
phosphorothio
nucleotid
modif
posit
eg
well
lock
nucleic
acid
among
wide
employ
build
block
rnai
applic
fulli
modifi
sirna
drastic
increas
halflif
human
serum
significantli
higher
activ
vectorbas
vivo
model
hbv
infect
compar
unmodifi
form
furthermor
introduct
modifi
nucleotid
improv
stabil
sirna
also
reduc
offtarget
effect
improv
antivir
activ
sirna
direct
highli
structur
target
region
present
chapter
describ
systemat
method
design
highli
potent
antivir
sirna
summar
fig
experiment
procedur
test
sirna
report
assay
gfp
report
assay
dualluciferas
report
assay
well
assay
infecti
virus
cell
viabil
assay
plaqu
reduct
assay
outlin
final
option
improv
properti
sirna
introduct
modifi
nucleotid
describ
first
major
step
design
highli
activ
sirna
consist
select
sirna
sequenc
favor
thermodynam
featur
thermal
stabil
end
well
base
prefer
activ
sirna
certain
posit
influenc
silenc
effici
sirna
design
sirna
public
avail
web
tool
use
exampl
given
tabl
advis
gener
sirna
pool
least
two
differ
web
tool
blast
option
appli
avoid
unspecif
bind
endogen
target
sequenc
therebi
reduc
offtarget
effect
exampl
sirna
predesign
use
rnai
design
invitrogen
describ
go
rnai
design
websit
invitrogen
see
tabl
b
choos
sirna
target
design
option
c
enter
complet
partial
target
sequenc
use
highli
conserv
region
viru
see
note
deselect
option
target
region
select
orf
utr
f
gc
content
set
minimum
maximum
g
select
default
motif
pattern
see
note
h
submit
press
rnai
design
button
summari
design
sirna
given
new
window
sort
output
choos
rank
select
sirna
star
copi
sequenc
gener
choos
best
sirna
obtain
design
tool
sirna
design
tool
includ
blast
option
ncbi
blast
follow
see
note
obtain
sirna
pool
subsequ
filter
respect
thermodynam
featur
convert
sequenc
obtain
antisens
strand
sirna
orient
antisens
strand
complementari
target
rna
see
fig
b
remov
duplic
sirna
ident
sirna
sequenc
exclud
sinc
singl
nucleotid
shift
sometim
influenc
effici
sirna
c
calcul
score
sirna
base
score
system
given
tabl
exclud
sirna
less
point
reynold
criteria
second
major
step
exclud
sirna
whose
antisens
strand
predict
form
secondari
structur
end
chang
gibb
free
energi
dg
sirna
antisens
strand
determin
neg
dg
valu
indic
stabl
secondari
structur
wherea
posit
dg
valu
indic
instabl
secondari
structur
result
high
degre
unfold
singlestrand
rna
dg
determin
use
public
avail
unafold
softwar
describ
softwar
extend
replac
mfold
softwar
zuker
go
renssela
bioinformat
web
server
see
tabl
use
dinamelt
web
server
b
select
applic
nucleic
acid
quikfold
choos
rna
energi
rule
field
rna
fold
fix
temperatur
hybrid
temperatur
modifi
use
rna
addit
sequenc
type
specifi
linear
set
window
necessari
e
submit
dinamelt
server
summari
potenti
fold
result
given
new
window
see
note
exclud
sirna
whose
antisens
strand
predict
form
secondari
structur
indic
least
one
structur
neg
dg
valu
structur
dg
valu
around
zero
fold
probabl
analyz
see
note
access
target
rna
sequenc
consid
third
major
step
sirna
design
procedur
consist
two
step
first
fold
entir
target
rna
molecul
second
determin
chang
gibb
free
energi
dg
local
rna
target
site
dg
determin
use
public
avail
softwar
use
preferenti
long
rna
sequenc
subsequ
describ
go
renssela
bioinformat
web
server
see
tabl
use
mfold
web
server
b
select
applic
rnafold
c
enter
name
sequenc
fold
choos
rna
sequenc
linear
fold
temperatur
fix
temperatur
modifi
use
rna
mfold
version
server
upper
bond
number
comput
fold
limit
less
long
sequenc
may
increas
comput
load
result
respons
time
set
window
necessari
e
sequenc
shorter
base
fold
immedi
march
longer
rna
sequenc
base
select
batch
enter
email
address
f
submit
entri
press
fold
rna
button
rna
sequenc
longer
base
fold
altern
burnet
institut
mfold
server
see
tabl
applic
submit
rna
sequenc
base
mfold
version
paramet
window
set
accord
mfold
version
describ
except
fold
temperatur
fix
addit
limit
upper
bond
number
comput
fold
renssela
bioinformat
web
server
burnet
institut
mfold
server
give
summari
potenti
fold
result
g
dg
calcul
number
potenti
secondari
structur
list
structur
beneath
view
individu
structur
neg
dg
stabl
secondari
structur
go
also
indic
higher
chanc
presenc
biolog
system
h
save
least
ten
structur
use
download
fold
button
find
correspond
target
structur
sirna
everi
potenti
fold
j
select
promis
sirna
target
site
check
follow
point
number
ident
similar
target
site
program
give
variou
structur
correspond
energi
dg
good
target
access
differ
structur
predict
increas
possibl
overal
target
access
ii
number
bond
high
number
bond
base
pair
within
target
sequenc
indic
strong
secondari
structur
less
access
sirna
k
determin
dg
valu
local
rna
target
structur
select
sirna
target
site
find
correspond
sirna
target
site
determin
base
within
target
site
involv
form
secondari
structur
add
also
base
base
pair
part
close
neighborhood
exampl
base
form
loop
even
part
sirna
target
site
ii
go
thermodynam
detail
chosen
structur
output
window
fold
result
iii
find
correspond
base
mark
number
add
singl
dg
valu
involv
base
energi
helic
loop
includ
one
base
structur
part
target
site
calcul
result
approxim
dg
local
usual
suffici
precis
calcul
dg
local
necessari
pleas
refer
turner
energi
rule
tabl
iv
calcul
chang
gibb
free
energi
dg
local
rna
target
structur
dg
local
exclud
sirna
whose
target
structur
show
strong
variabl
base
least
ten
fold
structur
differ
target
structur
furthermor
access
target
site
character
low
dg
local
valu
therefor
select
sirna
order
dg
local
valu
threshold
kcal
mol
select
sirna
potenti
effici
sirna
silenc
effici
test
report
assay
see
subhead
note
report
assay
method
choic
verifi
effici
select
sirna
viru
target
sequenc
clone
upstream
downstream
gfp
luciferas
report
cotransfect
select
sirna
viru
target
sequenc
partial
viral
sequenc
long
enough
simul
structur
environ
sirna
target
sequenc
contrast
long
sequenc
may
complic
revers
transcript
andor
pcr
amplif
viral
target
sequenc
may
neg
influenc
transfect
effici
eukaryot
cell
see
note
protocol
topo
clone
describ
follow
section
shorten
version
instruct
manual
see
note
topo
clone
allow
ligat
pcramplifi
target
sequenc
viru
either
term
ct
nt
indic
gfp
express
fuse
respect
cterminu
nterminu
target
sequenc
verifi
orient
insert
analyz
plasmid
restrict
analysi
end
advantag
use
least
one
restrict
site
locat
within
viru
target
sequenc
one
present
vector
see
note
clone
contain
insert
correct
orient
sequenc
confirm
origin
sequenc
mutat
see
subhead
item
cultur
clone
choic
ml
lb
medium
contain
mgml
ampicillin
isol
plasmid
dna
plasmid
dna
transfect
eukaryot
cell
must
clean
free
phenol
sodium
chlorid
prevent
cell
death
avoid
low
transfect
effici
dualluciferas
report
assay
method
measur
activ
firefli
renilla
luciferas
one
sampl
viru
target
sequenc
clone
untransl
region
renilla
luciferas
gene
infram
clone
requir
translat
stop
codon
renilla
luciferas
present
vector
clone
viru
target
sequenc
vector
subsequ
describ
firefli
luciferas
also
express
vector
allow
normal
renilla
luciferas
activ
isol
viru
dna
rna
use
commerci
avail
dna
rna
viru
isol
kit
base
rna
infram
clone
renilla
luciferas
gene
requir
design
pcr
primer
follow
common
rule
primer
contain
one
restrict
site
use
clone
vector
see
note
exampl
use
forward
primer
ccg
ctc
gag
nnn
nnn
nnn
nnn
nnn
revers
primer
ata
gtt
ta
g
cgg
ccg
c
nnn
nnn
nnn
nnn
nnn
enzym
recognit
site
xho
forward
primer
revers
primer
indic
upper
case
letter
lower
case
letter
show
addit
nucleotid
effici
restrict
site
locat
end
pcr
fragment
base
part
viral
target
sequenc
indic
nnn
place
tube
ice
ligat
dna
fragment
vector
previous
digest
xho
use
standard
protocol
transform
ligat
reaction
e
coli
cell
analyz
coloni
describ
subhead
step
first
function
assay
sirna
report
assay
advis
use
cell
line
also
employ
viru
assay
exampl
protocol
transient
transfect
hela
cell
plate
use
lipofectamin
transfect
reagent
describ
see
note
transfect
effici
cell
line
test
transfect
random
sirna
label
end
sirna
sens
strand
sirna
transfect
without
report
plasmid
recommend
use
fitc
distinguish
gfp
fluoresc
microscopi
seed
hela
cell
per
well
volum
ml
medium
without
antibiot
incub
overnight
co
combin
lipofectamin
dnasirna
mixtur
incub
least
min
add
final
mix
ml
cell
remov
cultur
medium
incub
overnight
co
one
topo
vector
describ
serv
report
cotransfect
sirna
see
subhead
first
analysi
sirna
silenc
effici
perform
use
fluoresc
microscopi
requir
filter
gfp
detect
replac
medium
transfect
cultur
cell
ml
pb
gfp
express
report
plasmid
determin
see
fig
highli
effici
sirna
strongli
reduc
gfp
express
compar
transfect
report
plasmid
without
sirna
control
sirna
effect
result
confirm
western
blot
analysi
describ
subhead
case
cotransfect
renilla
firefli
luciferas
measur
see
subhead
remov
medium
cultur
cell
wash
cell
ml
pb
remov
pb
aspir
add
ml
dtt
lysi
buffer
per
well
transfer
lysat
eppendorf
tube
boil
lysat
min
separ
protein
wv
sdspolyacrylamid
gel
see
note
transfer
protein
pvdf
membran
use
method
choic
control
protein
transfer
ponceau
stain
strip
membran
wash
tb
shake
membran
follow
wash
step
antiserum
incub
rins
membran
ttb
block
nonfat
milk
powder
ttb
h
room
temperatur
rins
membran
time
ttb
wash
time
min
ttb
incub
gfp
antiserum
dilut
ttb
h
room
temperatur
overnight
rins
membran
time
ttb
incub
secondari
goat
antirabbit
antibodi
conjug
horseradish
peroxidas
dilut
ttb
h
room
temperatur
overnight
rins
membran
time
ttb
detect
signal
use
method
choic
chemiluminesc
imag
develop
use
xray
film
strip
membran
wash
time
min
ttb
block
nonfat
milk
powder
ttb
h
nonfat
milk
powder
ttb
min
room
temperatur
confirm
equal
load
sampl
reprob
membran
antibodi
direct
housekeep
gene
exampl
actin
repeat
step
start
step
use
mous
monoclon
antiactin
antibodi
dilut
remov
growth
medium
cultur
cell
wash
cell
ml
pb
remov
pb
aspir
add
ml
passiv
lysi
buffer
plb
per
well
shake
cultur
plate
gentli
orbit
shaker
rock
platform
min
room
temperatur
cultur
plate
store
later
use
analyz
directli
transfer
lysat
tube
sediment
residu
cell
debri
centrifug
full
speed
tabletop
centrifug
transfer
clear
lysat
fresh
tube
subsequ
measur
repeat
measur
sampl
start
step
select
effici
sirna
follow
function
analysi
viru
assay
highli
potent
antivir
sirna
reduc
gfp
express
virtual
complet
western
blot
show
least
inhibit
renilla
luciferas
dualluciferas
report
assay
crucial
test
evalu
antivir
activ
design
sirna
assay
infecti
viru
two
method
vitro
test
describ
cell
viabil
assay
indirect
method
quantifi
effici
sirna
wherea
plaqu
reduct
assay
show
direct
inhibit
viru
replic
sirna
xttbase
cell
viabil
assay
use
quantif
cell
prolifer
viabil
metabol
activ
cell
cleav
yellow
tetrazolium
salt
orang
formazan
dye
absorb
measur
defin
wavelength
directli
correl
cell
viabil
recommend
use
xtt
reagent
due
high
sensit
compar
tetrazolium
salt
mtt
incub
min
ad
cell
viru
dilut
store
sever
minut
necessari
add
ml
per
well
dilut
viru
suspens
includ
neg
control
well
remain
uninfect
end
use
serumfre
medium
without
antibiot
handl
cell
ident
infect
cell
incub
min
co
see
note
remov
viru
suspens
add
ml
medium
contain
fc
antibiot
incub
co
begin
cell
viabil
assay
xtt
measur
prepar
adequ
amount
xtt
reagent
exampl
mix
ml
electroncoupl
reagent
ml
xtt
label
reagent
add
ml
per
well
fresh
xtt
reagent
incub
h
co
remov
medium
measur
absorb
microtit
plate
reader
defin
wavelength
nm
refer
wavelength
greater
nm
gener
plaqu
origin
viral
infect
singl
cell
reduct
viru
titer
show
directli
effici
sirna
viru
spread
prevent
altern
protocol
use
acceler
stain
see
note
effici
sirna
abl
reduc
viru
titer
least
one
order
magnitud
figur
show
exampl
plaqu
reduct
assay
select
antivir
sirna
show
high
effici
may
chemic
modifi
decreas
potenti
offtarget
effect
enhanc
serum
stabil
one
approach
reduc
offtarget
effect
prevent
incorpor
unwant
sens
strand
risc
exampl
achiev
lna
modif
end
introduct
modif
posit
sens
strand
howev
specif
reduct
offtarget
effect
observ
posit
antisens
strand
addit
modifi
theori
chemic
modif
sirna
also
result
increas
serum
stabil
practic
sirna
modif
often
accompani
decreas
silenc
effici
compar
unmodifi
sirna
lna
modif
introduc
posit
except
antisens
strand
caus
substanti
loss
silenc
effici
anoth
way
combin
high
silenc
effici
increas
serum
stabil
reduc
offtarget
effect
complet
modif
differ
nucleotid
analog
shown
sirna
target
hbv
genom
fig
howev
chemic
modif
depend
applic
well
viru
inhibit
strategi
describ
possibl
identifi
effici
sirna
virtual
given
viru
recent
exemplifi
echoviru
next
step
transfer
antivir
rnai
approach
vivo
model
one
main
challeng
effici
deliveri
sirna
desir
target
tissu
follow
chapter
describ
virusbas
approach
deliv
shrna
express
cassett
well
differ
strategi
applic
chemic
presynthes
sirna
order
identifi
conserv
region
viral
genom
advis
select
sequenc
variou
strain
perform
blast
search
region
high
homolog
consid
conserv
repres
suitabl
sirna
target
site
tuschl
motif
pattern
strongli
restrict
number
sirna
subsequ
select
may
becom
problem
short
sequenc
target
ncbi
blast
tool
orand
ensembl
blast
tool
use
homolog
search
see
tabl
summari
potenti
fold
fold
possibl
andor
softwar
arei
show
term
dg
rna
sequenc
form
secondari
structur
sirna
antisens
strand
give
neg
dg
valu
examin
structur
use
sirna
show
stemloop
structur
nucleotid
free
terminu
free
nucleotid
terminu
analys
sirna
meet
indic
criteria
first
check
anoth
partial
sequenc
viru
target
altern
threshold
dg
local
rna
target
site
adjust
especi
mani
sirna
remain
whose
antisens
strand
form
stabl
secondari
structur
see
also
note
end
select
least
four
sirna
order
dg
local
valu
threshold
reynold
criteria
chang
gener
best
includ
partial
target
rna
length
kb
span
sirna
target
sequenc
extend
protocol
troubl
shout
guid
topo
clone
found
complet
instruct
manual
provid
kit
long
viru
target
sequenc
use
polymeras
proofread
activ
sinc
amplifi
sequenc
lack
aoverhang
essenti
describ
clone
method
addit
incub
taq
polymeras
necessari
e
coli
transform
electropor
salt
solut
must
dilut
fourfold
final
concentr
mm
nacl
mm
mgcl
prevent
arc
option
ml
mm
bmercaptoethanol
ad
chemic
compet
e
coli
cell
follow
incub
ice
min
procedur
may
increas
transform
effici
store
mm
solut
bmercaptoethanol
vector
map
sequenc
avail
invitrogen
websit
see
tabl
vector
map
sequenc
avail
promega
websit
see
tabl
restrict
site
may
also
suitabl
case
custom
addit
base
effici
restrict
incub
time
extens
tabl
provid
new
england
biolab
see
tabl
use
cell
line
orand
transfect
reagent
requir
differ
condit
given
densiti
sdspolyacrylamid
gel
depend
molecular
weight
mw
target
sequenc
use
add
mw
gfp
around
kd
calcul
mw
target
sequenc
estim
though
sequenc
may
influenc
gel
mobil
lead
measur
weight
predict
valu
larii
aliquot
thaw
room
temperatur
reagent
heatlabil
incub
overnight
also
possibl
cell
plate
lower
densiti
moi
suitabl
mani
virus
case
may
need
adjust
control
infect
show
mani
individu
plaqu
reliabl
count
effect
sirna
appreci
reduc
number
plaqu
weak
sirna
may
lead
slight
reduct
larg
number
distinguish
plaqu
control
plate
simplifi
recognit
weak
sirna
may
desir
optim
possibl
fc
within
medium
may
interfer
viral
infect
effici
incub
time
depend
infect
cycl
specif
viru
neutral
red
well
crystal
violet
taken
healthi
cell
dead
cell
plaqu
therefor
appear
clear
circl
redviolet
background
clear
area
overlap
much
difficult
recogn
individu
plaqu
infect
time
reduc
plaqu
small
easili
read
tri
extend
infect
time
though
could
also
indic
defect
weaken
strain
stain
acceler
use
crystal
violet
solut
end
fix
cell
tca
min
room
temperatur
remov
agar
without
disturb
cell
monolay
add
ml
crystal
violet
solut
solut
pb
well
incub
min
room
temperatur
see
note
remov
stain
aspir
wash
pb
invert
plate
count
plaqu
well
calcul
viral
titer
describ
subhead
step
